Laura Sánchez‐Íñigo

1.5k total citations · 1 hit paper
9 papers, 857 citations indexed

About

Laura Sánchez‐Íñigo is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Laura Sánchez‐Íñigo has authored 9 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Laura Sánchez‐Íñigo's work include Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Diet, Metabolism, and Disease (4 papers). Laura Sánchez‐Íñigo is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Diet, Metabolism, and Disease (4 papers). Laura Sánchez‐Íñigo collaborates with scholars based in Spain, Italy and Israel. Laura Sánchez‐Íñigo's co-authors include Juan Pastrana Delgado, David Navarro‐González, Alejandro Fernández‐Montero, J. Alfredo Martínéz, JA Martínez, Diego Martínez‐Urbistondo, Delia D’Avola, Elisabetta Bugianesi, Ana E. Huerta and Manuel F. Landecho and has published in prestigious journals such as Medicine, Preventive Medicine and Obesity.

In The Last Decade

Laura Sánchez‐Íñigo

9 papers receiving 844 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The TyG index may predict the development of cardiovascular events

2015 386 citations Laura Sánchez‐Íñigo, David Navarro‐González et al. European Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Sánchez‐Íñigo Spain	6	537	354	345	123	112	9	857
Fernanda Satake Novaes Brazil	7	343 0.6×	228 0.6×	212 0.6×	107 0.9×	71 0.6×	11	616
Maria da Saúde de Oliveira Brazil	6	335 0.6×	217 0.6×	204 0.6×	93 0.8×	68 0.6×	7	584
Guenter Hoefle Austria	14	246 0.5×	215 0.6×	215 0.6×	118 1.0×	50 0.4×	17	652
Maobin Kuang China	15	381 0.7×	163 0.5×	360 1.0×	125 1.0×	71 0.6×	52	703
Jiani Xu China	3	313 0.6×	264 0.7×	209 0.6×	79 0.6×	29 0.3×	8	566
Sayaka Kadowaki Japan	16	146 0.3×	292 0.8×	136 0.4×	119 1.0×	60 0.5×	40	650
Ebenezer Oni United States	12	268 0.5×	296 0.8×	460 1.3×	59 0.5×	51 0.5×	26	753
Leay‐Kiaw Er Taiwan	6	246 0.5×	134 0.4×	192 0.6×	60 0.5×	65 0.6×	12	468
Alejandro Díaz González-Colmenero Mexico	8	228 0.4×	124 0.4×	152 0.4×	67 0.5×	36 0.3×	15	445
Özlem Tarçın Türkiye	14	184 0.3×	190 0.5×	117 0.3×	165 1.3×	62 0.6×	33	802

Countries citing papers authored by Laura Sánchez‐Íñigo

Since Specialization

Citations

This map shows the geographic impact of Laura Sánchez‐Íñigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Sánchez‐Íñigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Sánchez‐Íñigo more than expected).

Fields of papers citing papers by Laura Sánchez‐Íñigo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Sánchez‐Íñigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Sánchez‐Íñigo. The network helps show where Laura Sánchez‐Íñigo may publish in the future.

Co-authorship network of co-authors of Laura Sánchez‐Íñigo

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Sánchez‐Íñigo. A scholar is included among the top collaborators of Laura Sánchez‐Íñigo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Sánchez‐Íñigo. Laura Sánchez‐Íñigo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Martínez‐Urbistondo, Diego, Ana E. Huerta, David Navarro‐González, et al.. (2023). Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset. European Journal of Clinical Investigation. 53(10). e14036–e14036. 2 indexed citations

Sánchez‐Íñigo, Laura, David Navarro‐González, Diego Martínez‐Urbistondo, et al.. (2023). Repercussions of absolute and time-rated BMI “yo-yo” fluctuations on cardiovascular stress-related morbidities within the vascular-metabolic CUN cohort. Frontiers in Endocrinology. 13. 1087554–1087554. 4 indexed citations

Martínez‐Urbistondo, Diego, Delia D’Avola, David Navarro‐González, et al.. (2022). Interactive Role of Surrogate Liver Fibrosis Assessment and Insulin Resistance on the Incidence of Major Cardiovascular Events. Journal of Clinical Medicine. 11(17). 5190–5190. 2 indexed citations

Navarro‐González, David, Laura Sánchez‐Íñigo, Alejandro Fernández‐Montero, Juan Pastrana Delgado, & J. Alfredo Martínéz. (2016). TyG Index Change Is More Determinant for Forecasting Type 2 Diabetes Onset Than Weight Gain. Medicine. 95(19). e3646–e3646. 32 indexed citations

Sánchez‐Íñigo, Laura, David Navarro‐González, Juan Pastrana Delgado, Alejandro Fernández‐Montero, & J. Alfredo Martínéz. (2016). Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort. Journal of Hypertension. 34(7). 1257–1265. 99 indexed citations

Navarro‐González, David, Laura Sánchez‐Íñigo, Juan Pastrana Delgado, Alejandro Fernández‐Montero, & J. Alfredo Martínéz. (2016). Triglyceride–glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: The Vascular-Metabolic CUN cohort. Preventive Medicine. 86. 99–105. 271 indexed citations

Navarro‐González, David, Laura Sánchez‐Íñigo, Alejandro Fernández‐Montero, Juan Pastrana Delgado, & J. Alfredo Martínéz. (2016). Are all metabolically healthy individuals with obesity at the same risk of diabetes onset?. Obesity. 24(12). 2615–2623. 20 indexed citations

Sánchez‐Íñigo, Laura, David Navarro‐González, Alejandro Fernández‐Montero, Juan Pastrana Delgado, & JA Martínez. (2016). Risk of incident ischemic stroke according to the metabolic health and obesity states in the Vascular-Metabolic CUN cohort. International Journal of Stroke. 12(2). 187–191. 41 indexed citations

Sánchez‐Íñigo, Laura, David Navarro‐González, Alejandro Fernández‐Montero, Juan Pastrana Delgado, & J. Alfredo Martínéz. (2015). The TyG index may predict the development of cardiovascular events. European Journal of Clinical Investigation. 46(2). 189–197. 386 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact